Filing Details
- Accession Number:
- 0001384101-18-000052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-19 18:17:57
- Reporting Period:
- 2018-06-15
- Accepted Time:
- 2018-06-19 18:17:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1449535 | M Christopher Hall | 6000 Shoreline Court Suite 300 South San Francisco CA 94080 | President And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-06-15 | 10,509 | $0.80 | 42,964 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-06-15 | 10,509 | $9.00 | 32,455 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-06-19 | 9,491 | $0.80 | 41,946 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-06-19 | 9,491 | $9.05 | 32,455 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-06-15 | 10,509 | $0.00 | 10,509 | $0.80 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-06-19 | 9,491 | $0.00 | 9,491 | $0.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 69,491 | 2020-03-30 | No | 4 | M | Direct | |
| 60,000 | 2020-03-30 | No | 4 | M | Direct |
Footnotes
- The sale of common stock was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 16, 2017.
- Represents the aggregate of sales effected on the same day at different prices.
- Represents weighted average sales price. Sale prices for the transactions range from $9.00 to $9.01. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- Represents weighted average sales price. Sale prices for the transactions range from $9.00 to $9.17. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
- The option became exercisable as to 25% of the shares on March 15, 2011, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.
Billionaire Hedge Funds
